Literature DB >> 6699175

Role of endogenous secretin in acid-induced inhibition of human gastric function.

J H Kleibeuker, V E Eysselein, V E Maxwell, J H Walsh.   

Abstract

The role of secretin in the inhibition of gastric acid secretion that occurs during acidification of the gastric lumen was studied in nine healthy men. Gastric acid secretion was stimulated by 500-ml meals of 8% peptone solution, and the pH of the stomach was maintained at 5.5, 2.5, or 2.0 by intragastric titration. The increase in plasma secretin was measured, after extraction, by a new secretin radioimmunoassay. After determining the intravenous dose of secretin required to reproduce plasma secretin concentrations achieved during pH 2.5 and 2.0 meals, similar doses were given during administration of a pH 5.5 peptone meal. The doses of secretin led to plasma secretin concentrations that averaged 3.4 pM, not different from the 3.2 and 3.9 pM concentrations achieved during acidified meals. However, exogenous secretin infusion failed to inhibit acid secretion or gastrin response to peptone, although significant inhibitions occurred in both during peptone meals given at pH 2.5 or 2.0. When secretin infusions were given at fivefold higher rates, plasma gastrin responses again failed to demonstrate significant inhibition. Gastric emptying was inhibited significantly by both acidified peptone meals but only slightly (P = 0.053) during exogenous infusion of physiologic secretin doses. The decrease in acid secretion could be explained by decreased gastrin release, but neither of these findings could be explained by circulating secretin concentrations. These results cast strong doubt on a physiological role of secretin in inhibition of acid secretion in man.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699175      PMCID: PMC425044          DOI: 10.1172/JCI111239

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  pH threshold for release of secretin in normal subjects and in patients with duodenal ulcer and patients with chronic pancreatitis.

Authors:  J Fahrenkrug; O B Schaffalitzky de Muckadell; S J Rune
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

2.  Radioimmunossay of secretin in human plasma.

Authors:  L E Hanssen; P Torjesen
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

3.  Inhibition of histamine-stimulated gastric secretion by acid in the duodenum in man.

Authors:  D Johnston; H L Duthie
Journal:  Gut       Date:  1966-02       Impact factor: 23.059

4.  Dose-response relationship of the efect of secretin on acid and pepsin secretion in man.

Authors:  A Berstad; H Petersen
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

5.  Effect of secretin and cholecystokinin on pentagastrin-stimulated gastric secretion in man.

Authors:  A M Brooks; M I Grossman
Journal:  Gastroenterology       Date:  1970-07       Impact factor: 22.682

6.  Response to duodenal acidification in man. II. Effects on the gastric secretory response to pentagastrin.

Authors:  K G Wormsley
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

7.  Positioning of subject and of nasogastric tube during a gastric secretion study.

Authors:  M A Hassan; M Hobsley
Journal:  Br Med J       Date:  1970-02-21

8.  The role of secretin in the inhibition of gastric secretion by intraduodenal acid.

Authors:  A S Ward; S R Bloom
Journal:  Gut       Date:  1974-11       Impact factor: 23.059

9.  Effect of secretin on gastric function in normal subjects and in patients with duodenal ulcer.

Authors:  M D Dalton; A M Eisenstein; J H Walsh; J S Fordtran
Journal:  Gastroenterology       Date:  1976-07       Impact factor: 22.682

10.  Secretin responses to feeding and acid load.

Authors:  R K Yang; H R Li; J Eng; R Greenstein; E Straus; R S Yalow
Journal:  J Lab Clin Med       Date:  1983-07
View more
  9 in total

1.  To extract or not to extract in secretin radioimmunoassay?

Authors:  M Fried; C Schulthess; C Beglinger; B Müller; K Gyr
Journal:  Int J Pancreatol       Date:  1988-07

2.  Effect of low-dose exogenous secretin on pentagastrin- and meal-stimulated gastric acid secretion in humans.

Authors:  J Christiansen; B Hansen; L Hilsted; O B Schaffalitzky de Muckadell
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

3.  Secretin provocation in normal and duodenal ulcer subjects. Is the gastrin rise in Zollinger-Ellison syndrome paradoxic or exaggeration?

Authors:  C E Brady; S J Utts; J Dev
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

4.  Plaunotol inhibits postprandial gastrin release by its unique secretin-releasing action in humans.

Authors:  K Shiratori; S Watanabe; T Takeuchi; K Shimizu
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

5.  Characterization of secretin release in response to food and intraduodenal administration of fat and hydrochloric acid.

Authors:  E J Draviam; G Gomez; T Hashimoto; T Miyashita; F L Hill; T Uchida; P Singh; G H Greeley; J C Thompson
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

6.  Calcitonin gene related peptide inhibits basal, pentagastrin, histamine, and bethanecol stimulated gastric acid secretion.

Authors:  H J Lenz; M T Mortrud; J E Rivier; M R Brown
Journal:  Gut       Date:  1985-06       Impact factor: 23.059

7.  Regulation of gastric acid secretion by neurotensin in man. Evidence against a hormonal role.

Authors:  M H Mogard; V Maxwell; B Sytnik; J H Walsh
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

8.  Secretin is an enterogastrone in humans.

Authors:  C H You; W Y Chey
Journal:  Dig Dis Sci       Date:  1987-05       Impact factor: 3.199

Review 9.  Secretin as a neuropeptide.

Authors:  Samuel S M Ng; W H Yung; Billy K C Chow
Journal:  Mol Neurobiol       Date:  2002-08       Impact factor: 5.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.